Cagrilintide 10mg User Guide

This guide is for Cagrilintide 10mg. It walks through reconstitution, syringe math, conservative escalation, injection basics, side effects, and storage.

You can find this product here: Cagrilinitide.

---

ABOUT THIS PEPTIDE

Cagrilintide is an investigational long-acting amylin analog. Amylin is a hormone released with insulin after eating, and it helps signal fullness, slow gastric emptying, and regulate post-meal glucose behavior. In plain English, cagrilintide is studied as an appetite and satiety peptide, not as a stimulant or fat-burner.

The strongest interest around cagrilintide comes from obesity and metabolic research, especially when paired with semaglutide in the investigational combination often called CagriSema. That pairing is popular because GLP-1 signaling and amylin signaling approach appetite from different angles. The result, at least in trials, can look stronger than GLP-1 therapy alone.

On its own, cagrilintide is usually discussed as slower, steadier appetite support. It is not as culturally famous as semaglutide or tirzepatide, but the mechanism is serious and the clinical development program is real. The main limitation is that it is still investigational, so long-term real-world experience is thinner than approved metabolic medications.

Community reports tend to focus on appetite suppression, fullness, and occasional nausea or food aversion. Some users describe it as useful alongside GLP-style compounds, while others find it too flattening or too GI-heavy. The practical takeaway is that cagrilintide belongs in the appetite-regulation bucket, but it needs conservative dosing and patience.

Quick notes:

• Best known for: appetite, satiety, and metabolic research.
• Mechanism: long-acting amylin analog.
• Evidence level: active clinical development, especially in CagriSema-style research.
• Community theme: fullness and appetite control, sometimes strong nausea.
• Main watch-out: GI effects, over-suppressed appetite, and investigational status.

---

SUPPLIES YOU’LL NEED

• Insulin needles - https://www.amazon.com/dp/B07P2KK5P7
• Alcohol swabs - https://www.amazon.com/dp/B07F2MQ9NJ
• Reconstitution solution (bacteriostatic water) - https://progressionpeptides.com/product/bacteriostatic-water/

---

RECONSTITUTION (MIXING)

Each vial contains 10mg of cagrilintide. For this guide, add 2mL of bacteriostatic water.

Here’s what to do:

1. Draw up 200 units total of bacteriostatic water.
2. Inject the water slowly down the inside wall of the vial, not directly onto the powder.
3. Swirl gently. Do not shake.
4. Let it fully dissolve before drawing a dose.

With this mix, 1 unit on a U-100 insulin syringe = 0.05mg of cagrilintide.

Units on syringe	Approx dose
3 units	0.15mg
6 units	0.30mg
12 units	0.60mg
24 units	1.20mg
48 units	2.40mg
90 units	4.50mg

---

DOSING SCHEDULE

Cagrilintide is investigational and is commonly discussed as an amylin-analog appetite compound. A conservative research-style approach starts very low, such as 0.3mg once weekly, then increases slowly only if tolerated.

Community and trial-style discussions often reference stepwise escalation toward 2.4mg once weekly. Higher amounts are more aggressive and should not be treated as beginner territory.

---

HOW TO INJECT

Watch this quick video, it covers the basic subQ process: https://www.youtube.com/watch?v=e9NGueNM03I

The basics:

1. Wipe the top of the Cagrilintide 10mg bottle with an alcohol swab.
2. Draw your dose into the syringe.
3. Pinch a bit of belly fat or thigh, insert the needle, and push the plunger slowly.
4. Done. Rotate injection sites to avoid irritation.

---

SIDE EFFECTS AND CAUTIONS

Common GLP-style side effects include nausea, reduced appetite, reflux, constipation, diarrhea, bloating, fatigue, headache, and dehydration. Eating smaller meals and avoiding greasy/heavy meals usually helps.

Extra caution: cagrilintide can strongly reduce appetite and can overlap with GLP-style nausea/fullness. Do not stack with semaglutide, tirzepatide, retatrutide, or other appetite/glucose drugs without medical guidance. Be especially careful with diabetes medications, history of hypoglycemia, GI disease, eating disorders, pregnancy, breastfeeding, or dehydration risk.

Pause and reassess if nausea is persistent, vomiting occurs, hydration becomes difficult, abdominal pain is severe, or symptoms feel unusual for you.

---

STORAGE

Keep the bottle in the fridge after reconstitution: cold, dry, and dark. Avoid repeated warm-ups, direct light, and unnecessary vial punctures.

Unreconstituted powder is usually more stable than mixed solution, but the fridge is still the better default. If the solution becomes cloudy, changes color, grows particles, or looks wrong, stop and do not use it.

---

RESEARCH NOTES

• https://www.peptideprotocolwiki.com/peptides/cagrilintide/dosing
• https://www.glp3.wiki/articles/what-is-cagrilintide